UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

269th ENMC International Workshop:10 years of Clinical trials in DMD – What have we learned? 9–11 December 2022, The Netherlands

Naarding, Karin; Stimpson, Georgia; Ward, Susan J; Goemans, Nathalie; McDonald, Craig; Mercuri, Eugenio; Muntoni, Francesco; (2023) 269th ENMC International Workshop:10 years of Clinical trials in DMD – What have we learned? 9–11 December 2022, The Netherlands. Neuromuscular Disorders , 33 (11) pp. 897-910. 10.1016/j.nmd.2023.10.003. Green open access

[thumbnail of 1-s2.0-S0960896623007484-main.pdf]
Preview
Text
1-s2.0-S0960896623007484-main.pdf - Accepted Version

Download (1MB) | Preview

Abstract

There are multiple avenues for therapeutic development in Duchenne Muscular Dystrophy (DMD), which are highlighted in the first section of this report for the “10 years of Clinical trials in DMD – What have we learned?” workshop. This report then provides an overview of the presentations made at the workshop grouped into the following core themes: trial outcomes, disease heterogeneity, meaningfulness of outcomes and the utility of real-world data in trials. Finally, we present the consensus that was achieved at the workshop on the learning points from 10 years of clinical trials in DMD, and possible action points from these. This includes further work in expanding the scope and range of trial outcomes and assessing the efficacy of new trial structures for DMD. We also highlight several points which should be addressed during future interactions with regulators, such as clinical meaningfulness and the use of real-world data.

Type: Article
Title: 269th ENMC International Workshop:10 years of Clinical trials in DMD – What have we learned? 9–11 December 2022, The Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.nmd.2023.10.003
Publisher version: https://doi.org/10.1016/j.nmd.2023.10.003
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Duchenne muscular dystrophy, clinical trial, outcome measure, real world data, meaningfulness
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10179891
Downloads since deposit
13Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item